Cybex International to Relocate California Operations.

Business Editors

MEDWAY, MA--(BUSINESS WIRE)--June 27, 2000

Cybex International, Inc. (AMEX: CYB), a leading strength and cardiovascular equipment company, announced today that it will relocate the cardiovascular equipment assembly and Product Development operations currently performed in Irvine, California, to the company's Medway, Massachusetts, facility. The closing of the Irvine facility will result in a charge against second quarter earnings.

Peter C. Haines, President and Chief Executive Officer of Cybex, said, "We anticipate that the increased efficiencies we achieve by consolidating Product Development and production of all cardiovascular products into one facility will widen margins and contribute to profitability in the future." Haines added, "This move is expected to reduce both product cost and operating cost, as well as speed up shipment and delivery of these important Cybex products to our principal markets."

Cybex International, Inc. is a leading manufacturer of premium performance cardiovascular and strength training equipment for consumer and commercial use. Cybex and the Cybex Institute, a training and research facility, are dedicated to improving human performance based on an understanding of the diverse goals and needs of individuals of varying physical capabilities. Cybex designs and engineers each of its products and programs to reflect the natural movement of the human body, allowing for variation in training and assisting each unique user -- from the professional athlete to the rehabilitation patient -- to improve their daily human performance. For more information on Cybex and its product line, please visit the company's web site at www.eCybex.com.

This news release may contain forward-looking statements. There are a number of risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made above. These include, but are not limited to, competitive factors, technological and product developments, market demand, and uncertainties relating to the consolidation of the merged and acquired companies' businesses. Further information on these and other factors which could affect the Company's financial results can be found in the Company's previously filed Reports on Form 10-K for the year ended December 31, 1999, its Form 10-Q for the period ending March 31, 2000, and its proxy statement dated April 18, 2000.